Charles River Laboratories
For more than 70 years, Charles River Laboratories (CRL) delivers client-focused solutions for the specific testing and manufacturing requirements of biologics. CRL provides global regulatory compliant testing to support clients throughout the biologic development cycle. The assays provided range from cell line characterization, process validation studies and stability analysis to product release testing. Manufacturing services include cell banking, storage, fill and finish, and viral vaccine and antisera production.
- Cell banking and characterization
- Vaccine and cell therapy
- Viral clearance and TSE study
- Lot release testing
- Stability testing
- In vivo biosafety and potency testing
- Biosimilar testing
- Product characterization
After the acquisition of MPI Research in 2018, CRL can now provide comprehensive animal testing services to biopharmaceutical and medical devices worldwide. With state-of-art accredited AAALAC facilities and highly skilled staff, CRL helps customers to identify and address pharmacology or toxicology issues unique to the molecule, the indication, or the patient population. All the studies conducted at CRL are in accordance with domestic and international regulatory agencies, including FDA, EPA, USDA, EMEA, OECD, ICH, and JMHW.
For more specific information, please click the link
https://www.criver.com/products-services/research-models-services